CT-FFR for Coronary In-stent Stenosis Based on ISR-Net Algorithm

Sponsor
Beijing Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05131191
Collaborator
(none)
150
1
17
8.8

Study Details

Study Description

Brief Summary

CT-FFR(CT-derived flow reserve fraction) usually could not been measured accurately for in-stent lesions due to the serious interference with the metal structs. ISR-Net is a new algorithm in assessing the flow of coronary in-stent stenosis. We compare the CT-FFR value of in-stent lesions with the invasive FFR measured by pressure wire to evaluate the accuracy of ISR-Net algorithm. The research results are of great significance to solve the bottleneck problem of CT-FFR and expand its application scope.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CT-FFR measurement
  • Procedure: invasive FFR

Detailed Description

CT-FFR is an important noninvasive examination to evaluate the function of coronary artery disease. It can help clinicians make clinical decisions and reduce patients' invasive coronary angiography (ICA). The image quality of coronary CT angiography (CCTA) is the basis of CT-FFR measurement. Because metal stents seriously interfere with the imaging of CCTA, it is very difficult to measure the CT-FFR value of lesions in stents. However, a large number of patients need imaging follow-up evaluation after stenting. In the previous research, the investigators creatively invented a new algorithm ISR-Net and conducted a retrospective analysis. It is preliminarily proved that the algorithm can more accurately display the stenosis lesions in the stent than the previous imaging software, making it possible to calculate the CT-FFR of the lesions in the stent. At present, the algorithm has applied for a national invention patent. In order to transform to clinical application, further clinical verification is needed. This study will evaluate the accuracy of ISR-Net algorithm in assessing the function of coronary stent stenosis by carrying out prospective clinical trials and taking the blood flow reserve fraction (FFR) measured by pressure wire as the gold standard. At the same time, the standard process of CT-FFR measurement of in stent lesions was established. The research results are of great significance to solve the bottleneck problem of CT-FFR and expand its application scope.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Application of New Algorithm ISR-Net in Measuring CT-FFR of Coronary In-stent Stenosis.
Actual Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
patients with coronary metal stents implantation

Diagnostic Test: CT-FFR measurement
Patients were scanned with ≥ 64 row CT according to standard operating specifications. The software obtains the coronary CT angiography image file through the data communication interface. Based on the image processing algorithm, the centerline and contour of the target vessel can be extracted, and then the target vessel can be reconstructed to obtain the three-dimensional size information of the vessel; Based on hydrodynamics calculation and analysis, the fractional flow reserve (FFR) of each position of the target vessel is measured.
Other Names:
  • FFRCT
  • Procedure: invasive FFR
    Insert the pressure guide wire into the finger guide tube and push the pressure guide wire until the pressure sensor just comes out of the orifice of guiding catheter; Equalize PD and PA values;Push the pressure guide wire to the distal end of the lesion, and record the measured blood vessel and position;Record the resting Pd / PA of the pressure guide wire;Nitroglycerin and adenosine triphosphate were administered intravenously according to standard catheter laboratory specifications to achieve maximum hyperemia;Record the FFR value of the in-stent lesions.
    Other Names:
  • pressure wire
  • Outcome Measures

    Primary Outcome Measures

    1. To predict the sensitivity, specificity and accuracy of CT-FFR in the functional sense of in stent lesions based on ISR-Net algorithm. [one month]

    Secondary Outcome Measures

    1. To predict the functional accuracy of in stent lesions, PPV, NPV and area under ROC curve (AUC) [one month]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    General Inclusion Criteria:
    • Over 18 years old;

    • Be able to understand the purpose of the test and sign the informed consent form;

    • Previous intracoronary stent implantation;

    • According to the comprehensive clinical evaluation, coronary angiography and FFR were proposed;

    CTA image Inclusion Criteria:
    • The coronary CT angiography images showed that the reference vessel diameter of the stenosis segment in the stent was ≥ 2mm;

    • The stenosis degree of coronary stent diameter ≥ 30% and ≤ 90% by visual inspection.

    Exclusion Criteria:
    General exclusion criteria:
    • Previous coronary artery bypass grafting (CABG), artificial heart valve implantation, pacemaker or implantable defibrillator implantation;

    • There are persistent or active symptoms of clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure state (systolic blood pressure less than 90 mmHg), severe congestive heart failure (NYHA cardiac function grade III or IV) or acute pulmonary edema;

    • Acute myocardial infarction occurred within 7 days before enrollment;

    • Patients with other severe diseases are not suitable for clinical trials, such as complex congenital heart history, sick sinus syndrome, long QT syndrome, severe arrhythmia or tachycardia, severe asthma, severe or very severe chronic obstructive pulmonary disease, chronic renal function impairment (serum creatinine value > 1.5 mg / dL or creatinine clearance rate < 45ml / kg · 1.73m2);

    • There are contraindications to the use of disodium adenosine triphosphate;

    • Allergic to iodized contrast media;

    • Pregnancy or unknown pregnancy status;

    • The expected life is less than 2 months;

    • There are any other factors that the researchers believe are not suitable for inclusion or completion of this study.

    CTA image exclusion criteria:
    • The coronary artery image was obviously misplaced;

    • Coronary artery occlusion.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing Hospital Beijing China

    Sponsors and Collaborators

    • Beijing Hospital

    Investigators

    • Study Chair: Xue Yu, MD, Beijing Hospital, National Center of Gerontology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Xue Yu, project manager, Beijing Hospital
    ClinicalTrials.gov Identifier:
    NCT05131191
    Other Study ID Numbers:
    • CT-FFR for in-stent lesion
    First Posted:
    Nov 23, 2021
    Last Update Posted:
    Feb 1, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xue Yu, project manager, Beijing Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 1, 2022